{
  "id": 20428748,
  "title": "Johnson & Johnson vs. Novo Nordisk: Steady Uptrend vs. Flat Revenue",
  "url": "https://urgent.news/2026/11/17/johnson-johnson-vs-novo-nordisk-steady-uptrend-vs-flat-revenue-20428748",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-17T11:45:10.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/johnson-johnson-vs-novo-nordisk-steady-uptrend-vs-flat-revenue"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsJohnson & Johnson currently exhibits a stronger overall position by generating a substantially larger total revenue volume than Novo Nordisk.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}